• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Initiating activity of 3-tert-butyl-4-hydroxyanisole (3-BHA) and its metabolites in two-stage transformation of BALB/3T3 cells.

作者信息

Sakai A, Miyata N, Takahashi A

机构信息

Division of Microbiology, National Institute of Hygienic Sciences, Tokyo, Japan.

出版信息

Carcinogenesis. 1990 Nov;11(11):1985-8. doi: 10.1093/carcin/11.11.1985.

DOI:10.1093/carcin/11.11.1985
PMID:2225330
Abstract

3-tert-Butyl-4-hydroxyanisole (3-BHA) and its metabolites, tert-butyl-1,4-benzoquinone (BQ) and 3-tert-butyl-5-methoxy-1,2-benzoquinone (BHAoQ), were tested for initiating activity in a two-stage transformation assay using BALB/3T3 cells. Cells were treated first with a test chemical and then with the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA). In the absence of TPA the test chemicals did not induce cell transformation. With the promoting treatment, 3-BHA and BQ induced dose-dependent cell transformation. There were statistically significant increases in the proportion of dishes with transformed foci in the cultures treated with 30 micrograms/ml 3-BHA plus TPA (15 of 24 dishes, P less than 0.005) and with 0.4 microgram/ml BQ plus TPA (12 of 22 dishes, P less than 0.02) as compared to the cultures treated with DMSO plus TPA (5 of 24 dishes). BHAoQ caused a non-significant increase in transformation frequency in the presence of TPA. In conclusion, 3-BHA and BQ had an initiating activity in the cell transformation system and the potency of BQ was approximately 100 times higher than that of 3-BHA.

摘要

相似文献

1
Initiating activity of 3-tert-butyl-4-hydroxyanisole (3-BHA) and its metabolites in two-stage transformation of BALB/3T3 cells.
Carcinogenesis. 1990 Nov;11(11):1985-8. doi: 10.1093/carcin/11.11.1985.
2
Promoting activity of 3-tert-butyl-4-hydroxyanisole (BHA) in BALB/3T3 cell transformation.促进3-叔丁基-4-羟基茴香醚(BHA)在BALB/3T3细胞转化中的活性。
Cancer Lett. 1997 May 19;115(2):213-20. doi: 10.1016/s0304-3835(97)04731-9.
3
Initiating activity of quinones in the two-stage transformation of BALB/3T3 cells.醌在BALB/3T3细胞两阶段转化中的起始活性。
Carcinogenesis. 1995 Mar;16(3):477-81. doi: 10.1093/carcin/16.3.477.
4
DNA damage in forestomach epithelium from male F344 rats following oral administration of tert-butylquinone, one of the forestomach metabolites of 3-BHA.
Carcinogenesis. 1991 Apr;12(4):703-8. doi: 10.1093/carcin/12.4.703.
5
Inhibition by 2(3)-tert-butyl-4-hydroxyanisole and other antioxidants of epidermal ornithine decarboxylase activity induced by 12-O-tetradecanoylphorbol-13-acetate.2(3)-叔丁基-4-羟基茴香醚及其他抗氧化剂对12-O-十四烷酰佛波醇-13-乙酸酯诱导的表皮鸟氨酸脱羧酶活性的抑制作用
Cancer Res. 1983 Jun;43(6):2555-9.
6
Improvement of carcinogen identification in BALB/3T3 cell transformation by application of a 2-stage method.通过应用两阶段方法改进BALB/3T3细胞转化中致癌物的鉴定
Mutat Res. 1989 Oct;214(2):285-96. doi: 10.1016/0027-5107(89)90172-3.
7
Initiating potential of 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2), butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and 3,3',4',5,7-pentahydroxyflavone (quercetin) in two-stage mouse skin carcinogenesis.
Cancer Lett. 1987 Dec;38(1-2):49-56. doi: 10.1016/0304-3835(87)90199-6.
8
Effects of 3-tert-Butyl-4-hydroxyanisole and its hydroquinone and quinone metabolites on rat and human embryonic cells in culture.3-叔丁基-4-羟基茴香醚及其对苯二酚和醌代谢产物对培养的大鼠和人胚胎细胞的影响。
Toxicol In Vitro. 1988;2(4):291-6. doi: 10.1016/0887-2333(88)90048-3.
9
Mutagenicity of 3-tert-butyl-4-hydroxyanisole (BHA) and its metabolites in short-term tests in vitro.3-叔丁基-4-羟基茴香醚(BHA)及其代谢产物在体外短期试验中的致突变性。
Mutat Res. 1990 Jun;241(2):125-32. doi: 10.1016/0165-1218(90)90115-i.
10
Retinoic acid and butylated hydroxyanisole inhibit promoter-enhanced transformation in vitro.
Cancer Lett. 1986 Nov;33(2):161-5. doi: 10.1016/0304-3835(86)90020-0.